146 related articles for article (PubMed ID: 9186541)
21. [Long-lasting remission of Burkitt's disease in African children. Apropos of 6 cases].
Plo JK; Rain JD; Andoh J; Tea DN; Essoh NP
Med Trop (Mars); 1986; 46(2):141-6. PubMed ID: 3724411
[TBL] [Abstract][Full Text] [Related]
22. Intrathecal chemoprophylaxis in the prevention of central nervous system relapse in Burkitt's lymphoma.
Nkrumah FK; Neequaye JE; Biggar R
Cancer; 1985 Jul; 56(2):239-42. PubMed ID: 3839158
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of a patient with seropositive human immunodeficiency virus with high risk Burkitt's leukemia.
Greenberg AL; Droller DG
Cancer; 1994 Aug; 74(4):1261-4. PubMed ID: 8055447
[TBL] [Abstract][Full Text] [Related]
24. Burkitt's lymphoma-- what is new?
Abinya ON
East Afr Med J; 2008 May; 85(5):205-6. PubMed ID: 18814529
[No Abstract] [Full Text] [Related]
25. [Reye syndrome in a child having received chemotherapy].
Dubern B; Alessandri JL; Montbrun A; Attali T; Pilorget H; Samperiz S
Arch Pediatr; 1998 Mar; 5(3):342-3. PubMed ID: 10328010
[No Abstract] [Full Text] [Related]
26. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.
Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A
Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843
[TBL] [Abstract][Full Text] [Related]
27. Liposomal cytarabine in cerebrospinal fluid.
Boyd K; Jenner M; Treleaven J; Kenny J; Rhoades E
Br J Haematol; 2009 Jun; 145(6):679. PubMed ID: 19076172
[No Abstract] [Full Text] [Related]
28. Cytarabine induced noncardiogenic pulmonary edema in a case of acute lymphoblastic leukemia.
Yegin ZA; Aki S; Sucak G; Yagci M
Int J Lab Hematol; 2007 Dec; 29(6):482-3. PubMed ID: 17988309
[No Abstract] [Full Text] [Related]
29. Intensive chemotherapy in patients with generalized Burkitt's lymphoma.
Ziegler JL; Bluming AZ; Magrath IT; Carbone PP
Int J Cancer; 1972 Sep; 10(2):254-61. PubMed ID: 4574467
[No Abstract] [Full Text] [Related]
30. Curability of advanced Burkitt's lymphoma in children by intensive short-term chemotherapy.
Gasparini M; Rottoli L; Massimino M; Gianni MC; Ballerini E; Ravagnani F; Pupa S; Fossati-Bellani F
Eur J Cancer; 1993; 29A(5):692-8. PubMed ID: 8471326
[TBL] [Abstract][Full Text] [Related]
31. Optimizing the use of the hyperCVAD regimen: Clinical vignettes and practical management.
Rausch CR; Jabbour EJ; Kantarjian HM; Kadia TM
Cancer; 2020 Mar; 126(6):1152-1160. PubMed ID: 31794095
[No Abstract] [Full Text] [Related]
32. Effective multi-agent chemotherapy for advanced abdominal lymphoma and FAB L3 leukemia of childhood.
Toogood IR; Tiedemann K; Stevens M; Smith PJ
Med Pediatr Oncol; 1993; 21(2):103-10. PubMed ID: 8433675
[TBL] [Abstract][Full Text] [Related]
33. Combined modality therapy for adults with small noncleaved cell lymphoma (Burkitt's and non-Burkitt's types).
Bernstein JI; Coleman CN; Strickler JG; Dorfman RF; Rosenberg SA
J Clin Oncol; 1986 Jun; 4(6):847-58. PubMed ID: 3711961
[TBL] [Abstract][Full Text] [Related]
34. Non-hodgkins lymphoma.
Mead G; Woodcock J; Young C
Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
[No Abstract] [Full Text] [Related]
35. The effect of cerebral spinal fluid replacement on acute myelopathy induced by intrathecal therapy of leukemia.
Wang Z; Xu W; Liu L; Ding Z
Leuk Res; 2011 Jun; 35(6):e79-80. PubMed ID: 21247632
[No Abstract] [Full Text] [Related]
36. [Treatment strategy of gray zone lymphomas].
Maruyama D
Rinsho Ketsueki; 2014 Oct; 55(10):1912-9. PubMed ID: 25297755
[No Abstract] [Full Text] [Related]
37. Intraventricular concentration times time (C x T) methotrexate and cytarabine for patients with recurrent meningeal leukemia and lymphoma.
Moser AM; Adamson PC; Gillespie AJ; Poplack DG; Balis FM
Cancer; 1999 Jan; 85(2):511-6. PubMed ID: 10023723
[TBL] [Abstract][Full Text] [Related]
38. Central nervous system involvement in Burkitt's lymphoma.
Ziegler JL; Bluming AZ; Morrow RH; Fass L; Carbone PP
Blood; 1970 Dec; 36(6):718-28. PubMed ID: 5536703
[No Abstract] [Full Text] [Related]
39. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
40. Excessive spinal cord toxicity from intensive central nervous system-directed therapies.
Watterson J; Toogood I; Nieder M; Morse M; Frierdich S; Lee Y; Moertel CL; Priest JR
Cancer; 1994 Dec; 74(11):3034-41. PubMed ID: 7954266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
